This month we provide you with a deal analysis  overview of life science partnering, M&A and financing in July 2014.

July 2014 By Raveena Bhambra Q2 was full of deals, coupled with the talk of potential deals, and overall it finished on a high with a large volume of agreements coming together in June.

This article reflects on the latest industry trends in the co-marketing and co-promotion dealmaking in the biopharma sector. Two major forms of joint marketing are used to promote a product on the market, namely co-promotion and co-marketing. They are also referred to as joint marketing alliances.

Recent industry analysis gathered from our database Current Agreements, showcases a high volume of dealmaking activity in the distribution deal type among the pharma and biotech companies worldwide.

This month we provide you with an overview of life science deal making activity, covering partnering, M&A and financing in June 2014.

Discovery, preclinical and clinical stage pharma and biotech partnering forms a critical part of the drug candidate commercialization process.

This month we provide you with an overview of life science deal making activity, covering partnering, M&A and financing in May 2014.

With 85 deals announced, the first quarter of 2014 started strongly for life science M&A

Smaller biotech deal making pips smaller pharma to the Q1 post by signing 300 deals, which is over half the amount made in the whole quarter

This article talks about the industry trend analysis of signing royalty and revenue financing deals among life science sectors